Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, et al
Published April 12, 2024
On September 16, 2025 , the FDA issued warning letters to more than 50 compounding pharmacies and telehealth companies , including Hims & Hers , for selling unapproved GLP-1s and making misleading claims
It belongs to the family of growth hormone releasing peptides that stimulate the pituitary gland and brain to produce and release more natural growth hormone
Other potential benefits include enhanced blood-glucose management, improvements in cardiovascular health, reductions in inflammation, and possibly even liver support for those with non-alcoholic fatty liver disease